Authors: Gissmann, L Osen, W Muller, M Jochmus, I

Citation: L. Gissmann et al., Therapeutic vaccines for human papillomaviruses, INTERVIROLO, 44(2-3), 2001, pp. 167-175

Authors: Osen, W Peiler, T Ohlschlager, P Caldeira, S Faath, S Michel, N Muller, M Tommasino, M Jochmus, I Gissmann, L

Citation: W. Osen et al., A DNA vaccine based on a shuffled E7 oncogene of the human papillomavirus type 16 (HPV 16) induces E7-specific cytotoxic T cells but lacks transforming activity, VACCINE, 19(30), 2001, pp. 4276-4286

Authors: Osen, W Jochmus, I Muller, M Gissmann, L

Citation: W. Osen et al., Immunization against human papillomavirus infection and associated neoplasia, J CLIN VIRO, 19(1-2), 2000, pp. 75-78

Authors: Borchers, A Braspenning, J Meijer, J Osen, W Gissmann, L Jochmus, I

Citation: A. Borchers et al., E7-specific cytotoxic T cell tolerance in HPV-transgenic mice, ARCH VIROL, 144(8), 1999, pp. 1539-1556

Authors: Munz, C Obst, R Osen, W Stevanovic, S Rammensee, HG

Citation: C. Munz et al., Alloreactivity as a source of high avidity peptide-specific human CTL, J IMMUNOL, 162(1), 1999, pp. 25-34

Authors: Schafer, K Muller, M Faath, S Henn, A Osen, W Zentgraf, H Benner, A Gissmann, L Jochmus, I

Citation: K. Schafer et al., Immune response to human papillomavirus 16 L1E7 chimeric virus-like particles: Induction of cytotoxic T cells and specific tumor protection, INT J CANC, 81(6), 1999, pp. 881-888